Schizophrenia Trial, Recruiting NCT07569471 Sponsor: University of Toronto Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT07569471
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who have been diagnosed with Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, or Delusional Disorder (based on self-report)
  • People who are currently experiencing symptoms related to psychosis, as measured by a standard clinical scale (confirm with trial site)
  • People who are currently receiving outpatient treatment for psychosis, such as medication management with a psychiatrist or GP, case management, or community mental health support
  • People who have access to a personal device such as a smartphone, tablet, or computer with wifi or mobile data

Who may not be able to join:

  • People who are not able to give informed consent to participate in the trial
  • People who do not have one of the listed diagnoses (Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, or Delusional Disorder)
  • People who are not currently experiencing delusions
  • People who are not currently receiving outpatient treatment
  • People who are currently receiving a specific type of talking therapy for psychosis known as CBTp (Cognitive Behavioural Therapy for psychosis)
  • People who do not have access to a personal device such as a smartphone, tablet, or computer with wifi or mobile data

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Micheal W Best, PhD, University of Toronto

Phone: 647-689-6098

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Toronto
Registry
ClinicalTrials.gov
Start date
31 March 2026
Est. completion
30 August 2027

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Brief Core Schema Scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov